Panagora Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-49,123
| Closed | -$958K | – | 1616 |
|
|
2022
Q1 | $958K | Buy |
49,123
+38,416
| +359% | +$749K | 0.01% | 964 |
|
|
2021
Q4 | $175K | Buy |
+10,707
| New | +$175K | ﹤0.01% | 1502 |
|
|
2018
Q2 | – | Sell |
-49,934
| Closed | -$1.54M | – | 2431 |
|
|
2018
Q1 | $1.54M | Buy |
+49,934
| New | +$1.54M | 0.01% | 983 |
|
|
2017
Q3 | – | Sell |
-391
| Closed | -$10K | – | 2521 |
|
|
2017
Q2 | $10K | Buy |
+391
| New | +$10K | ﹤0.01% | 2437 |
|
|
2015
Q3 | – | Sell |
-1,771
| Closed | -$57K | – | 2439 |
|
|
2015
Q2 | $57K | Buy |
+1,771
| New | +$57K | ﹤0.01% | 2111 |
|
|
2014
Q3 | – | Sell |
-37,118
| Closed | -$1.26M | – | 2365 |
|
|
2014
Q2 | $1.26M | Sell |
37,118
-1,455
| -4% | -$49.5K | 0.01% | 1014 |
|
|
2014
Q1 | $1.22M | Buy |
+38,573
| New | +$1.22M | 0.01% | 1099 |
|